Pancreatic ductal adenocarcinoma cells regulated the gemcitabine‐resistance function of CAFs by LINC00460

Pancreatic ductal adenocarcinoma (PDAC) is a highly fatal malignancy with extremely poor prognosis. Gemcitabine resistance is a major challenge in the treatment of PDAC. Here, we showed that LINC00460 was associated with the response to gemcitabine both in PDAC patients and PDAC‐PDX. After knocking...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiao‐Xu, Li, Jian‐Hui, Ni, Xuhao, Wu, Xiao, Hou, Xun, Li, Ya‐Xiong, Li, Shi‐Jin, Zhao, Wei, Yin, Xiao‐Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633316/
https://www.ncbi.nlm.nih.gov/pubmed/36047966
http://dx.doi.org/10.1111/cas.15547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633316/
https://www.ncbi.nlm.nih.gov/pubmed/36047966
http://dx.doi.org/10.1111/cas.15547

Ejemplares similares